Hosted on MSN2mon
QNRX: International Sites Participating in QRX003 NS Study, Studying QRX003 for Additional Diseases, in Younger PopulationsU.S. and International Sites participating in QRX003 NS study, Expanding to study QRX003 for additional indications and in younger patient populations Quoin Pharmaceuticals (NASDAQ:QNRX ...
Hosted on MSN1mon
QNRX Stock Hits 52-Week Low at $0.42 Amid Market ChallengesI n a turbulent market environment, QNRX stock has reached a new 52-week low, trading at just $0.42. According to InvestingPro data, while the company maintains a FAIR financial health score and ...
Quoin Pharmaceuticals, Ltd. (QNRX) stock price is 0.31 and Quoin Pharmaceuticals, Ltd. (QNRX) 10-day simple moving average is 0.31. Quoin Pharmaceuticals, Ltd. (QNRX) stock price is 0.31 and Quoin ...
(RTTNews) - Quoin Pharmaceuticals, Inc. (QNRX), a clinical-stage specialty pharmaceutical company, on Thursday, announced additional clinical data supporting the efficacy of its investigational ...
1 Day QNRX 7.41% DJIA -0.03% Russell 2K 0.37% Health Care/Life Sciences -0.88% ...
Analyst Naz Rahman from Maxim Group reiterated a Buy rating on Quoin Pharmaceuticals (QNRX – Research Report) and keeping the price target at $2.00. Naz Rahman has given his Buy rating due to a ...
ASHBURN, Va., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty ...
(RTTNews) - Quoin Pharmaceuticals, Ltd. (QNRX) Tuesday announced positive interim clinical data from its ongoing Investigator Pediatric Netherton Syndrome clinical study using QRX003. The data ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results